| 000 | 00943 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516084630.0 | ||
| 264 | 0 | _c20150922 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1936-2692 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aDrug profiles. _h[electronic resource] |
| 260 |
_bThe American journal of managed care _c02 2012 |
||
| 300 |
_aSP35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlbumin-Bound Paclitaxel |
| 650 | 0 | 4 |
_aAlbumins _xeconomics |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xeconomics |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 | _aMedical Oncology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xeconomics |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 773 | 0 |
_tThe American journal of managed care _gvol. 18 _gno. 1 Spec No. _gp. SP35 |
|
| 999 |
_c21671417 _d21671417 |
||